A systems approach to clinical oncology: Focus on breast cancer

Por Abramovitz, Mark, Leyland-Jones, Brian
Publicado em 2006

Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist

Por Hamish Wright, D, Metters, Kathleen M, Abramovitz, Mark, Ford-Hutchinson, Anthony W
Publicado em 1998

Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner

Por Dey, Nandini, Young, Brandon, Abramovitz, Mark, Bouzyk, Mark, Barwick, Benjamin, De, Pradip, Leyland-Jones, Brian
Publicado em 2013

Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis

Por Willis, Scooter, Villalobos, Victor M., Gevaert, Olivier, Abramovitz, Mark, Williams, Casey, Sikic, Branimir I., Leyland-Jones, Brian
Publicado no PLoS One (2016)

Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay

Por Abramovitz, Mark, Ordanic-Kodani, Maja, Wang, Yuefang, Li, Zhenhong, Catzavelos, Charles, Bouzyk, Mark, Sledge, George W., Moreno, Carlos S., Leyland-Jones, Brian
Publicado em 2008

Nuclear localization of prostaglandin E(2) receptors

Por Bhattacharya, Mousumi, Peri, Krishna G., Almazan, Guillermina, Ribeiro-da-Silva, Alfredo, Shichi, Hitoshi, Durocher, Yves, Abramovitz, Mark, Hou, Xin, Varma, Daya R., Chemtob, Sylvain
Publicado em 1998

The Effect of a DNA Repair Gene on Cellular Invasiveness: Xrcc3 Over-Expression in Breast Cancer Cells

Por Martinez-Marignac, Veronica L., Rodrigue, Amélie, Davidson, David, Couillard, Martin, Al-Moustafa, Ala-Eddin, Abramovitz, Mark, Foulkes, William D., Masson, Jean-Yves, Aloyz, Raquel
Publicado em 2011

Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial

Por Dowsett, Mitch, Procter, Marion, McCaskill-Stevens, Worta, de Azambuja, Evandro, Dafni, Urania, Rueschoff, Josef, Jordan, Bruce, Dolci, Stella, Abramovitz, Mark, Stoss, Oliver, Viale, Giuseppe, Gelber, Richard D., Piccart-Gebhart, Martine, Leyland-Jones, Brian
Publicado em 2009

Wnt signaling in triple negative breast cancer is associated with metastasis

Por Dey, Nandini, Barwick, Benjamin G, Moreno, Carlos S, Ordanic-Kodani, Maja, Chen, Zhengjia, Oprea-Ilies, Gabriella, Tang, Weining, Catzavelos, Charles, Kerstann, Kimberly F, Sledge, George W, Abramovitz, Mark, Bouzyk, Mark, De, Pradip, Leyland-Jones, Brian R
Publicado no BMC Cancer (2013)

Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials

Por Leyland-Jones, Brian R., Ambrosone, Christine B., Bartlett, John, Ellis, Matthew J.C., Enos, Rebecca A., Raji, Adekunle, Pins, Michael R., Zujewski, Jo Anne, Hewitt, Stephen M., Forbes, John F., Abramovitz, Mark, Braga, Sofia, Cardoso, Fatima, Harbeck, Nadia, Denkert, Carsten, Jewell, Scott D.
Publicado em 2008

Protein-Coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy

Por Long, Qi, Johnson, Brent A., Osunkoya, Adeboye O., Lai, Yu-Heng, Zhou, Wei, Abramovitz, Mark, Xia, Mingjing, Bouzyk, Mark B., Nam, Robert K., Sugar, Linda, Stanimirovic, Aleksandra, Williams, Daron J., Leyland-Jones, Brian R., Seth, Arun K., Petros, John A., Moreno, Carlos S.
Publicado em 2011

A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy

Por Williams, Casey B, McMahon, Caitlin, Ali, Siraj M, Abramovitz, Mark, Williams, Kirstin A, Klein, Jessica, McKean, Heidi, Yelensky, Roman, George, Thomas J, Elvin, Julia A, Soman, Salil, Lipson, Doron, Chmielecki, Juliann, Morosini, Deborah, Miller, Vincent A, Stephens, Philip J, Ross, Jeffrey S, Leyland-Jones, Brian
Publicado no Onco Targets Ther (2015)

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

Por Leyland-Jones, Brian, Gray, Kathryn P., Abramovitz, Mark, Bouzyk, Mark, Young, Brandon, Long, Bradley, Kammler, Roswitha, Dell’Orto, Patrizia, Biasi, Maria Olivia, Thürlimann, Beat, Harvey, Vernon, Neven, Patrick, Arnould, Laurent, Maibach, Rudolf, Price, Karen N., Coates, Alan S., Goldhirsch, Aron, Gelber, Richard D., Pagani, Olivia, Viale, Giuseppe, Rae, James M., Regan, Meredith M.
Publicado no Breast Cancer Res Treat (2015)

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial

Por Leyland-Jones, Brian, Gray, Kathryn P., Abramovitz, Mark, Bouzyk, Mark, Young, Brandon, Long, Bradley, Kammler, Roswitha, Dell'Orto, Patrizia, Biasi, Maria Olivia, Thürlimann, Beat, Lyng, Maria B., Ditzel, Henrik J., Harvey, Vernon J., Neven, Patrick, Treilleux, Isabelle, Rasmussen, Birgitte Bruun, Maibach, Rudolf, Price, Karen N., Coates, Alan S., Goldhirsch, Aron, Pagani, Olivia, Viale, Giuseppe, Rae, James M., Regan, Meredith M.
Publicado no Breast Cancer Res Treat (2015)